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Normal pressure hydrocephalus (NPH) is a syndrome comprising gait disturbance,
cognitive decline and urinary incontinence that is an unique model of reversible
brain injury, but it presents as a challenging spectrum of disease cohorts. Diffusion
Tensor Imaging (DTI), with its ability to interrogate structural white matter patterns
at a microarchitectural level, is a potentially useful tool for the confirmation and
characterization of disease cohorts at the clinical-research interface. However, obstacles
to its widespread use involve the need for consistent DTI analysis and interpretation tools
across collaborator sites. We present the use of DTI profiles, a simplistic methodology to
interpret white matter injury patterns based on the morphology of diffusivity parameters.
We examined 13 patients with complex NPH, i.e., patients with NPH and overlay from
multiple comorbidities, including vascular risk burden and neurodegenerative disease,
undergoing extended CSF drainage, clinical assessments, and multi-modal MR imaging.
Following appropriate exclusions, we compared the morphology of DTI profiles in such
complex NPH patients (n = 12, comprising 4 responders and 8 non-responders) to
exemplar DTI profiles from a cohort of classic NPH patients (n = 16) demonstrating
responsiveness of white matter injury to ventriculo-peritoneal shunting. In the cohort of
complex NPH patients, mean age was 71.3 ± 7.6 years (10 males, 2 females) with a
mean MMSE score of 21.1. There were 5 age-matched healthy controls, mean age was
73.4 ± 7.2 years (1 male, 4 females) and mean MMSE score was 26.8. In the exemplar
cohort of classic NPH patients, mean age was 74.7 ± 5.9 years (10 males, 6 females)
and mean MMSE score was 24.1. There were 9 age-matched healthy controls, mean
age was 69.4 ± 9.7 years (4 males, 5 females) and mean MMSE score was 28.6. We
found that, despite the challenges of acquiring DTI metrics from differing scanners across
collaborator sites and NPH patients presenting as differing cohorts along the spectrum of
disease, DTI profiles for responsiveness to interventions were comparable. Distinct DTI
characteristics were demonstrated for complex NPH responders vs. non-responders.
The morphology of DTI profiles for complex NPH responders mimicked DTI patterns
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found in predominantly shunt-responsive patients undergoing intervention for classic
NPH. However, DTI profiles for complex NPH non-responders was suggestive of atrophy.
Our findings suggest that it is possible to use DTI profiles to provide a methodology
for rapid description of differing cohorts of disease at the clinical-research interface. By
describing DTI measures morphologically, it was possible to consistently compare white
matter injury patterns across international collaborator datasets.
Keywords: normal pressure hydrocephalus, complex, comorbidities, MRI, DTI
INTRODUCTION
NPH was first described in 1965 by Hakim and Adams as a
condition of “symptomatic occult hydrocephalus with ‘normal’
cerebrospinal fluid (CSF) pressures” (1, 2). It classically comprises
of a triad of gait disturbance, cognitive decline and urinary
incontinence associated with ventriculomegaly in the absence
of persistently elevated intraventricular CSF pressures. The
diagnostic challenge is that the clinical features of NPH are
commonly found in functional decline from aging or other
neurodegenerative conditions. It is therefore possible that “many
patients with a potentially reversible condition are misdiagnosed
as having Alzheimer’s disease or vascular dementia and vice versa”
(3, 4). Although NPH is an apparently rare condition accounting
for an estimated 5% of dementias, it is more likely that its true
incidence is underestimated, due to the confounding factors of
multiple comorbidities in the elderly population (5). However,
unlike other conditions within the dementia spectrum, features
of the NPH syndrome may be reversed by the insertion of a CSF
shunt.
There is published data demonstrating that the condition
is reversible across differing populations worldwide. Recent
neurology practice guidelines concluded that there was evidence
for “96% chance subjective improvement and 83% chance
improvement on timed walk test at 6 months” and that
shunting was possibly effective in idiopathic NPH (6). Somewhat
surprisingly, increasing age in NPH does not decrease the chance
of shunting being successful. Few conditions in the elderly are
known to demonstrate such levels of response to intervention.
This should therefore elevate the importance of the study of NPH
within aging research as an urgent priority (7).
NPH presents as a challenging collection of patient cohorts
along a spectrum of disease. Neuropsychological profiling, gait/
balancemeasurements and CSF infusion studiesmay help predict
which patients have the potential to improve with surgical
intervention. However, such techniques require significant
patient cooperation for meaningful testing to occur. This may
not be possible for patients presenting at the late or complex part
of the NPH spectrum who are less able to participate in active
testing methods. In these types of NPH cohorts, supplementary
imaging methods to confirm and characterize NPH features
are of critical importance. These methods provide supporting
information in evaluating the NPH component remediable to
CSF diversion in order to balance the risks vs. benefits of surgical
intervention in patients where multiple clinical confounders co-
exist.
Yet, one of the major obstacles in the development of novel
tools for the interpretation of NPH imaging findings is that the
pathogenesis for classic NPH is still unknown. Published data
have been contradictory across different imaging modalities [see
Keong et al., 2016 (8) for a comprehensive review]. Studies have
demonstrated congruence with different hypotheses involving
structural changes, cerebral blood flow and CSF hydrodynamics
(9). It is thought that biomechanical forces, such as tissue
distortion caused by ventricular dilatation may result in CSF
and interstitial fluid stasis. This causes an increase of interstitial
fluid pressure, leading to reversal of fluid flow, which then
results in the failure of drainage of neurotoxic compounds
such as amyloid-β (10, 11). Studies have also demonstrated
reduced periventricular blood flow and impaired cerebrovascular
autoregulation in NPH, suggesting that watershed ischaemia in
the deep white matter and/or leakiness of damaged vasculature
may be the starting point for the process of accumulation of
toxic waste products that results in the increase of interstitial
fluid pressure (11, 12). Conversely, increased CSF stroke volume
through the aqueduct has been found in the NPH population
(13–15) despite normal CSF pressures. These processes, or a
combination of them, may disrupt the cerebral mantle and the
white matter tract connections serving the cortex in a spectrum
of injury processes. It is possible that “some types of disruption
may be more tolerable (i.e., more reversible) than others” (16).
Imaging methodology that is able to simultaneously document
differing injury patterns, such as axonal loss, compression,
stretching and/or oedema would be greatly advantageous in
understanding the cohorts presenting with NPH.
Diffusion Tensor Imaging (DTI) is a methodology that lends
itself to the understanding of intricate structural changes at
a microarchitectural level by using mathematical modeling of
water diffusion properties. As the displacement of fluid in
compartments is critical within the NPH spectrum, studies have
shown that DTI has been able to demonstrate different patterns
of white matter injury consistent with the symptomatology
of the NPH disorder (16). DTI has also been found to
differentiate NPH from other cohorts such as those with other
types of ventriculomegaly, chronic hydrocephalus as well as
Alzheimer’s disease, Parkinson’s disease, and other dementias
(17–19). However, there are challenges in DTI acquisition and
interpretation that prevent its more widespread uptake at the
clinical-research interface. As DTI imaging is performed at
different technical specifications across multiple scanners and
sites, there is a lack of understanding of how to harmonize
interpretation of DTI measures and so, derive knowledge of
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injury patterns from different cohorts of disease. DTI post-
processing and analysis methods may also be dependent on
availability of software tools and computing infrastructure.
This confounds the efforts of interested collaborators to share
common findings across international working groups and to
discover new targets for intervention.
In this study, we present the use of a novel methodological
tool for DTI interpretation that illustrates the ideal of the new
praxis of translational medicine, in which a patient-centered
approach to disease is promoted and prioritized. In such an
ideal, NPH patients within their respective patient cohorts
presenting to international collaborators would have access to
the same DTI interpretation and understanding of their disease
process, through an ability to share common knowledge of
imaging markers for thresholds of reversible vs. irreversible brain
injury. In order to overcome the challenges of applying DTI
interpretation techniques across collaborator sites, new tools are
needed to address our gaps of understanding. We present the use
of a simplistic DTI interpretation methodology that leverages on
existing capabilities at the clinical/research interface to convert
DTI measures into a consistent morphological classification for
more rapid comparisons of clinical cohorts across sites.
MATERIALS AND METHODS
The study comprised a prospective cohort of patients with
complex NPH undergoing management at the National
Neuroscience Institute (NNI), Singapore. The study protocol
was approved by the local research ethics committee (CIRB
2016/2627). A cohort of healthy controls was recruited under a
subsequent study (CIRB 2017/2854). Written informed consent
was obtained from all participants or, in cases of dementia
(MMSE <24/30), their legal representatives, for inclusion in the
study.
Subjects
Thirteen patients diagnosed with complex NPH undergoing
the extended CSF drainage protocol were selected for the
study from the NPH programme at the National Neuroscience
Institute, Singapore between 2016 and 2017. Participants were
recruited with a particular focus on the complex NPH subtype
(further described below), and therefore presented with multiple
comorbidities co-existing. Additionally, five age-matched healthy
controls who were functionally independent and had no
neurological conditions were recruited from the population.
A comparator dataset of a cohort of 16 patients with classic
NPH attending Addenbrooke’s Hospital, Cambridge University
Hospitals NHS Trust and nine age-matched healthy controls,
served as the exemplar for the analysis and interpretation of DTI
profiles. Details of patient characteristics, study protocol, and
ethical approval for the exemplar dataset, who were studied pre-
and 2 weeks post-operatively after successful shunting, have been
previously published (16).
Protocol for NPH Programme
Patients accepted for testing in the NPH protocol had
clinical descriptions consistent with either probable or possible
NPH, according to criteria in published guidelines (20). All
patients demonstrated communicating hydrocephalus, with
ventriculomegaly defined as an Evans’ index (maximum width of
frontal horns of the lateral ventricles divided by the transverse
inner diameter of the skull) ≥0.30, or a Bicaudate index
(minimum intercaudate distance divided by the brain width
along the same line) ≥0.25. Patients with probable NPH had
at least two out of three features of the NPH triad of gait
disturbance, cognitive impairment, and urinary incontinence.
Patients with possible NPH either had (a) incontinence and/or
cognitive impairment in the absence of an observable gait
or balance disturbance or (b) gait disturbance or dementia
alone. Within the NPH programme, we termed patients
amenable to standard testing and management according to
international guidelines as having “classic NPH.” Typically,
these patients demonstrated significantly positive responses
to high-volume tap testing and were offered shunt insertion
without further supplementary testing. However, patients who
demonstrated low/ borderline positive results on tap testing or
had comorbidities confounding the assessment of short-term
responsiveness to CSF drainage were offered the extended CSF
drainage protocol.
We also identified a separate subtype of NPH patients
presenting with multiple comorbidities co-existing, in particular
overlay from vascular risk burden and neurodegenerative
diseases. These patients had clinical symptoms and signs
consistent with probable/possible NPH according to
international and Japanese guidelines (20–22), and had strong
neuroradiological features supportive of the NPH diagnosis.
However, due to overlay, testing their CSF responsiveness
was difficult. We termed this subtype as “complex NPH.”
Further management was required to identify and optimize
other concurrent conditions before testing. “Where NPH
features coexisted with other neurological, psychiatric, or
general medical disorders, symptoms must be deemed not to
be entirely attributable to these conditions” (20). In cases with
neurodegenerative overlay, patients were referred for further
evaluation via the NPH programme following confirmation
that they did not fit diagnostic criteria for Alzheimer’s and
Parkinson’s diseases, and/or had; limited response to disease-
modifying drugs such as levodopa. Patients with cardiac risk
were assessed as being of no higher than moderate risk for
surgical intervention prior to being offered testing in the NPH
programme.
All participants in this study had complex NPH and
underwent insertion of a lumbar drain to facilitate the extended
CSF drainage protocol. In two participants, failure of drainage led
to the conversion of the lumbar drain to insertion of an Ommaya
reservoir for testing. In one of the latter, significant psycho-
behavioral issues resulted in failed MR imaging; this patient was
subsequently excluded from the analysis. CSF drainage in this
patient resulted in improvement in behavioral symptoms and the
patient underwent completion of ventriculo-peritoneal shunting
following their exit from the study.
The remaining 12 participants underwent the full NPH
programme for CSF drainage, including clinical gait and
cognitive testing, as well as pre- and post-drainage inpatient
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MR imaging. Patients with a lumbar drain in-situ underwent
a 3-day drainage/7-day global assessment protocol, achieving
≥300 mls total CSF withdrawal whereas the patient undergoing
serial reservoir taps had a modified protocol achieving ≥150–
200 mls total CSF withdrawal to account for the tolerance
needed for more rapid drainage and increased infection
risk.
Imaging Acquisition and Post-processing
All MR imaging data for this study were acquired with a 3.0-
T MR scanner (Ingenia, Philips Medical Systems, Best, the
Netherlands), including 3D T1, T2, FLAIR, and DTI sequences.
DTI was obtained using a single-shot echo-planar sequence
with a slice thickness of 2.3mm. Images were acquired in 20
gradient directions with the following parameters: b = 0 and
1,000 s/mm2, TR = 7,274ms; TE = 80ms; FOV 220 × 220mm;
and matrix = 96 × 96, resulting in a voxel size of 2.3 ×
2.3 × 2.3mm, with SENSE factor of 2.5. A few patients were
downgraded to the 1.5-T scanner at equivalent specifications
due to MR safety concerns. All DTI processing was performed
by using ExploreDTI (ExploreDTI, PROVIDI Lab, Utrecht, the
Netherlands).
DTI Analysis
Following corrections of subject motion and eddy current
distortions, tract pathways were reconstructed using whole
brain tractography. Due to dual technical constraints of
scanning specifications and fiber distortion in the presence of
significant ventriculomegaly, automated tractography extraction
only reliably generated key periventricular white matter tracts.
This “at-risk” model of white matter, including projection
fibers (corticospinal tract), commissural/callosal fibers (corpus
callosum, anterior commissure), and key association tracts
(typically inferior longitudinal, fronto-occipital, and uncinate
fasciculi) but excluding short association fibers, was found to be
reproducible in all participants.
We performed DTI analysis and interpretation according
to published methodology. We also derived disease-specific
(n = 16) and human control exemplar data (n = 9) for DTI
profiles from the published dataset (16). DTI measures, involving
six similar regions-of-interest (ROI), were used to generate an
overall estimate of the exemplar for mean DTI measures of
periventricular white matter. We have previously confirmed
the comparability and reliability of DTI measures, extracted
using ROI methodology, across different preferred software
tools (16).
Gait, Balance, and Cognitive Assessments
Patients underwent physiotherapy-led examinations of the
10m walking test, Tinetti gait and balance examination, and
had a Mini-Mental State Examination (MMSE) carried out
by occupational therapists. Inpatient assessment was further
corroborated with the patient’s own reported measures of
functional performance at home in the early period following
discharge. Using a simple report scale (from – to +100%
levels), patients and/or caregivers were asked to grade their own
perceived levels of improvement or deterioration at home to the
nearest 10%, with 0 being no perceivable difference, following
TABLE 1 | Clinical characteristics of complex NPH patients.
Age Sex MMSE NPH symptoms Other comorbidities
NNPH01 77 M 16 Gait disturbance, memory impairment, urinary
incontinence
Hypertension, diabetes mellitus, IHD, multifactorial
dementia, CKD
NNPH03 74 M 26 Predominantly gait disturbance Hypertension, parkinsonism
NNPH04 72 M 28 Predominantly gait disturbance Parkinsonism, previous stroke
NNPH05 74 F 11 Gait disturbance, memory impairment, urinary
incontinence
Hypertension, hyperlipidaemia, diabetes mellitus,
vascular parkinsonism, dementia
NNPH06 73 F 15 Gait disturbance, memory impairment, urinary
incontinence
Hypertension, hyperlipidaemia, diabetes mellitus,
vascular dementia, bladder dysfunction
NNPH07 67 M 21 Gait disturbance, memory impairment, urinary
incontinence
Hypertension, hyperlipidaemia, lumbar spondylosis,
and degenerative disc disease
NNPH08 71 M 28 Predominantly gait disturbance, mild memory
impairment, urinary frequency
Hypertension, hyperlipidaemia, diabetes mellitus,
IHD, SIADH
NNPH09 81 M 29 Gait disturbance, urinary incontinence Hypertension, hyperlipidaemia, parkinsonism,
cervical spondylosis
NNPH10 67 M 20 Gait disturbance, memory impairment, urinary
incontinence
Hypertension, hyperlipidaemia, diabetes mellitus,
aortic sclerosis, cervical spondylosis
NNPH11 55 M 12 Gait disturbance, memory impairment, urinary
incontinence
Hypertension, Korsakoff’s syndrome, behavioral
disturbance
NNPH12 82 M 17 Predominantly gait and cognitive disturbance Hypertension, hyperlipidaemia, IHD, parkinsonism,
COPD
NNPH13 63 M 30 Predominantly gait disturbance, urinary
frequency
Hyperlipidaemia, cervical and lumbar spondylosis
IHD, ischaemic heart disease; CKD, chronic kidney disease; SIADH, Syndrome of inappropriate antidiuretic hormone secretion; COPD, Chronic obstructive pulmonary disease.
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admission for CSF drainage. A positive response to CSF drainage
was defined as an increase of ≥10% in any measure of inpatient
gait, balance or cognitive testing (23) and ≥20% functional
improvement on the patient’s own self-report measure.
Statistical Analyses
Analyses were performed using SPSS Statistics Version 23.0
(IBM Corp., Armonk, NY, USA). Between-group and within-
group comparisons for DTI measures were tested with paired-
samples and independent-samples t-test. Mann–Whitney U
and Wilcoxon signed-rank tests were used for other variables.
Spearman’s rank correlation was used for correlations. All
statistical tests were two-tailed and significance level was set at
p< 0.05. All group means and DTI profile graphs were generated
with Microsoft Excel Version 15.23 (Microsoft Corp., Redmond,
WA, USA).
RESULTS
Clinical Characteristics
Following one exclusion, the study cohort included 12
participants (10 males, 2 females) with mean age 71.3 ±
7.6 years. All patients presented with gait disturbance, 58.3% had
cognitive impairment, and 58.3% had urinary incontinence or
known bladder dysfunction (Table 1). All patients with complex
NPH completed a baseline MMSE pre-drainage; mean MMSE
was 21.1. MMSE scores were not significantly different between
responder (Mean MMSE = 23.3) and non-responder (Mean
MMSE = 20.0) groups. The cohort of complex NPH patients in
the Singapore study was similar in clinical composition to the
exemplar dataset derived from the Cambridge study of classic
NPH patients (n = 16) in terms of gender (10 male, 6 female)
and age (mean age of 74.7 ± 5.9 years), but differed in ethnicity.
Classic NPH patients presented with mean MMSE = 24.1, just
TABLE 2 | Difference in DTI measures between complex NPH and healthy controls.
DTI measure MR1 p-value MR2 p-value
FA % difference between Complex NPH (all) vs. HC 0.225 0.921 −0.450 0.881
% difference between Complex NPH responders vs. HC 2.928 0.323 −0.901 0.820
% difference between Complex NPH non-responders vs. HC −1.126 0.716 −0.225 0.939
MD % difference between Complex NPH (all) vs. HC 14.461 0.023 12.815 0.019
% difference between Complex NPH responders vs. HC 9.236 0.049 11.038 0.035
% difference between Complex NPH non-responders vs. HC 17.079 0.012 13.704 0.036
L1 % difference between Complex NPH (all) vs. HC 14.272 0.008 12.236 0.009
% difference between Complex NPH responders vs. HC 10.310 0.015 10.270 0.019
% difference between Complex NPH non-responders vs. HC 16.261 0.005 13.210 0.019
L2and3 % difference between Complex NPH (all) vs. HC 15.070 0.043 13.803 0.031
% difference between Complex NPH responders vs. HC 8.525 0.107 12.212 0.050
% difference between Complex NPH non-responders vs. HC 18.334 0.020 14.599 0.056
Italics indicate p-values; bold indicate significant p-values at a significance level of 0.05.
TABLE 3 | Pre-lumbar drain vs. post-lumbar drain DTI; mean (SD).
DTI measure Cohort WBT Pre-LD WBT Post-LD % change p-value
FA NNI Complex NPH (all) 0.445 (0.021) 0.442 (0.023) −0.674 0.514
NNI Complex NPH responders 0.457 (0.011) 0.440 (0.019) −3.720 0.044
NNI Complex NPH non-responders 0.439 (0.023) 0.443 (0.026) 0.911 0.450
MD NNI Complex NPH (all) 9.530 (0.993) 9.393 (0.828) −1.438 0.385
NNI Complex NPH responders 9.095 (0.404) 9.245 (0.515) 1.649 0.363
NNI Complex NPH non-responders 9.748 (1.148) 9.467 (0.973) −2.883 0.210
L1 NNI Complex NPH (all) 14.420 (1.233) 14.163 (1.056) −1.782 0.251
NNI Complex NPH responders 13.920 (0.529) 13.915 (0.613) −0.036 0.978
NNI Complex NPH non-responders 14.671 (1.434) 14.286 (1.240) −2.624 0.251
L2and3 NNI Complex NPH (all) 7.086 (0.874) 7.008 (0.728) −1.101 0.555
NNI Complex NPH responders 6.683 (0.344) 6.910 (0.472) −0.036 0.179
NNI Complex NPH non-responders 7.287 (1.006) 7.057 (0.854) −2.624 0.187
Italics indicate p-values; bold indicate significant p-values at a significance level of 0.05.
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above the dementing range. The age-matched healthy controls in
the Singapore study (1 male, 4 female) had a mean age of 73.4 ±
7.2 years and mean MMSE was 26.8. The Cambridge exemplar
dataset had nine age-matched healthy controls (4 males, 5
females; mean age of 69.4 ± 9.7 years) and mean MMSE = 28.6,
the best of all available cohorts.
In the current study, eight out of the 12 patients were able to
complete a 10m walking test at 0, 48, and 72 h CSF drainage.
One patient could not be assessed at 48 h and their response
was assessed purely on the last measure. One patient missed
their baseline assessment and two patients were not able to
undergo any gait testing; their scores were excluded from gait
analysis and their response assessed based on other domains
and functional improvement, such as level of dependence for
sit/stand transfers or balance. Median time for the 10m walk was
12.9 s (IQR = 11.8–28.5 s) at 0 h and 14.8 s (IQR = 12.8–19.1 s)
at 72 h CSF drainage.
Comparisons Between DTI Parameters
As expected, the majority of the cohort of complex NPH
patients were non-responders. Of the 12 participants who were
included in the analysis, four responded to CSF drainage and
were subsequently offered definitive surgical intervention in
the form of ventriculo-peritoneal shunting. We confirmed that
DTI measures (FA, MD, L1, and L2and3) were statistically
different between cohorts [complex NPH vs. classic NPH
patients (p < 0.001), healthy controls in Cambridge vs.
Singapore (p ≤ 0.001)]. When patients were compared to
healthy controls within the individual sites, nearly all DTI
measures were significantly different between groups. Pre-
drainage, both complex NPH responders and non-responders
demonstrated significant differences in MD (axonal disruption)
and L1 (stretch/compression) compared to healthy controls.
However, there were only significant differences in L2and3
compared to healthy controls in the complex NPH non-
responder group (Table 2), suggesting that the white matter
microstructure in the complex NPH responders was better
preserved (less stretch/oedema). Following CSF drainage, only
the group of complex NPH responders demonstrated changes in
DTI measures sufficient to cause a significant overall change in
FA (Table 3).
DTI Profiles Across NPH Cohorts
Differing NPH patient cohorts and healthy controls could be
differentiated by the position of their DTI profiles within the
spectrum of diffusivity measures (see Figures 1, 2). As NPH
patients displayed worsening functional performance along the
disease spectrum (for example, mean MMSE = 24.1 vs. 21.1
for Classic vs. Complex NPH, respectively), their DTI profiles
concurrently worsened to match, across all diffusivity measures.
The morphology of DTI profiles also matched the performance
of healthy controls (mean MMSE = 28.6 vs. 26.8 for Cambridge
vs. Singapore healthy controls). Nevertheless, in individual
collaborator sites, DTI profiles for patients were consistently
worse than controls across all diffusivity measures. When pre-
intervention DTI profiles for complex NPH patients were plotted
as percentage differences between patients and healthy controls
FIGURE 1 | DTI profiles as radar graphs representing differences across classic NPH, complex NPH, and healthy control cohorts. Due to variations in scanning
acquisition between collaborator sites, differences in DTI metrics may not be statistically meaningful. However, DTI profiles provide a methodological tool for
comparability across cohorts. As NPH patients displayed worsening functional performance along the disease spectrum (for example, mean MMSE = 24.1 vs. 21.1
for classic vs. complex NPH, respectively), their DTI profiles concurrently worsened to match, across all diffusivity measures. The morphology of DTI profiles also
matched the performance of healthy controls (mean MMSE = 28.6 vs. 26.8 for Cambridge vs. Singapore healthy controls).
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FIGURE 2 | DTI profiles as line graphs across classic NPH, complex NPH (responder and non-responder), and healthy control cohorts. Differing NPH patient cohorts
and healthy controls could be differentiated by the position of their DTI profiles within the spectrum of diffusivity measures. DTI profiles for Cambridge healthy controls*
were the most preserved (highest FA, lowest MD, L1, and L2and3), whereas DTI profiles for complex NPH non-responders† were the most disrupted (lowest FA,
highest MD, L1 and L2and3).
(see Figure 3), DTI profiles for complex NPH responders were
more preserved compared to non-responders at baseline.
Morphology of DTI Profiles for Responders
vs. Non-responders
When the responses of NPH patients to CSF drainage
were plotted as percentage changes between pre- and post-
intervention diffusivity measures, the morphology of DTI
profiles for complex NPH patients responding to CSF drainage
matched that of classic NPH patients responding to successful
shunting in the exemplar dataset, albeit with a differing
magnitude of changes (see Figure 4). However, when the
percentage changes pre- and post-intervention were plotted
for complex NPH non-responders, DTI profiles demonstrated
entirely different morphology compared to responders from
either complex or classic NPH cohorts. When the means of
diffusivity parameters were considered concurrently, changes
in DTI profiles for complex NPH responders in Singapore
undergoing extended CSF drainage mimicked patterns of
changes seen in predominantly shunt-responsive patients with
classic NPH in Cambridge. Such patterns [decreased fractional
anisotropy (FA), increased mean diffusivity (MD), decreased
axial (L1) with increased radial diffusivities (L2and3)] were seen
consistently across all diffusivity measures (see Figures 5, 6).
Furthermore, such patterns were not seen in complex NPH non-
responders, who often exhibited changes in the exact opposite
direction to responders. Instead, the changes seen in non-
responders (an increase in fractional anisotropy (FA), with
passive reduction of all other diffusivity measures following
CSF drainage) were consistent with water diffusivity patterns
in the presence of atrophy. The interpretation of diffusivity
measures using DTI profiles also corresponded with visual
representations of tractography models for responders vs. non-
responders (Figure 5).
Correlation of CSF Responsiveness From
Lumbar Drainage With Surgical Outcome
Five patients (four responders and one patient excluded from
analysis due to lack of imaging compliance) underwent surgical
intervention, with six ventriculo-peritoneal shunts placed. All
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responders maintained their predicted responses following
shunting. One responder developed a delayed abdominal
pseudocyst with subacute infection. He had no evidence of
infection on CSF sampling but had drainage of the pseudocyst
FIGURE 3 | DTI profiles for complex NPH vs. healthy controls—radar graphs
represent percentage (%) differences between pre-intervention patients and
controls, differentiated by their post-intervention responses. The larger the DTI
radar graph, the greater the differences between patients and controls. This
graph demonstrates that compared to healthy controls, DTI profiles for
complex NPH responders were more preserved compared to non-responders
at baseline.
with temporary shunt externalization, due to concerns of
ascending infection. He subsequently had a shunt reinsertion
on the contralateral side without neurological deterioration.
Two responders reported post-operative improvement exceeding
that of testing levels. At 1 year post-shunting, all complex
and classic NPH responders maintained their good outcomes.
Good outcomes were primarily reflected in improvement of gait
symptoms. In terms of urinary symptoms, one responder had
subjective improvement in incontinence and two responders
reported no change; one responder had known pre-existing
bladder dysfunction. One non-responder subsequently died from
a cerebrovascular accident, a known comorbidity, outside the
study. Another had delayed improvement at home but declined
surgery.
DISCUSSION
In this study, we demonstrate the utility of using the morphology
of DTI parameters to compare DTI profiles across collaborator
sites, despite significantly different datasets. Due to the differing
MR scanners and specifications unique to each collaborator site,
it would not ordinarily be possible to directly compare DTI
findings. The methodology of DTI profiles provides a framework
for the rapid characterization of diffusivity measures to describe
patient cohorts at the clinical-research interface that supports
the new praxis of patient-centered international collaborative
research.
Technical Challenges of Data
Harmonization
The challenges of comparing imaging datasets between differing
collaborating units are well-accepted. Apart from MR field
FIGURE 4 | The morphology of DTI responses to CSF drainage—radar graphs represent percentage (%) changes between pre- and post-intervention DTI profiles in
patients. The morphology of DTI profiles for complex NPH responders matched that of classic NPH responders, albeit with a differing magnitude of changes. DTI
profiles for complex non-responders demonstrated entirely different morphology to responders with either complex or classic NPH.
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FIGURE 5 | (A) DTI periventricular white matter tractography model. (Above, left) A typical complex NPH responder demonstrating structural integrity despite white
matter disruption. (Below, left) A typical complex NPH non-responder demonstrating severe paucity of tracts and white matter damage. (B) DTI profiles (means with
standard error bars) for complex NPH responders, non-responders and classic NPH cohorts. Patterns of directional changes in diffusivity measures for complex NPH
responders were consistent with classic NPH, whereas directional changes for non-responders were suggestive of atrophy. MR1 = pre-intervention;
MR2 = post-intervention.
strengths, an analysis study by Cetin Karayumak et al. (24)
illustrated differences in inter- and intra- specific scanners. For
accurate analysis, harmonization and resolution of differences
both across and within scanners are usually required. Inter-
scanner differences can be found in both DTI measures such
as fractional anisotropy and mean diffusivity, and structural
measures, such as cortical thickness, and range from tissue-
specific to regional differences. Types of intra-scanner differences
include variability in receiver coils, reconstruction algorithms,
magnetic fields, and acquisition parameters (25). Several methods
have been developed to correct such issues. To combat structural
variability, it is possible to use a physical phantom framework
for monitoring and detection of scanner-related changes (26).
Techniques such as generation of z-scores (27–29) and regression
of covariates (30, 31) have been used to statistically resolve
the differences in specific diffusion measures. These challenges
can confound the establishment of international thresholds for
comparison of cohorts within a spectrum of disease.
Whilst such work is still necessary, good scan-rescan
repeatability and cross-scanner comparability have already
been confirmed across differing sites and scanners, supporting
the feasibility of using DTI measures derived from multiple
collaborating sites (32). Ongoing efforts have focused upon
achieving harmonizing of acquisition parameters and applying
relevant corrections to the generation of DTI metrics. However,
few studies have sought to understand the comparability of
using the morphology of DTI changes as a form of consistent
DTI interpretation across scanner sites. In this study, we
present a simplistic methodology for use at the clinical-research
interface that does not seek to directly address correction of
diffusivity measures per se. Instead, we propose the use of
DTI profiles to enable collaborators to confirm and characterize
the comparability of their cohorts by providing a further layer
of transparency, prior to the application of higher statistical
methods. The checks afforded by DTI profiles also enable rapid
detection of outliers for diffusivity parameters expected for local
cohorts and allows individual units to ascertain if their presenting
disease cohorts are comparable to international or open-access
datasets of disease. The ability to perform these checks at the
clinical-research interface contributes to the development of
patient-centered collaborative research networks.
NPH as a Model of Disease Cohorts
NPH as a disease continuum is critical to the development
and study of DTI profiles because it serves as a both a model
of reversible and irreversible brain injury. In our previous
work in classic NPH patients, we have shown that it is
possible to use DTI methodology to confirm and characterize
differing pathophysiological processes occurring concurrently
(16). Compared to age-matched healthy controls, NPH patients
exhibited “distinct profiles of white matter injury.” These profiles
could be entirely described by changes in anisotropic indices
that are specific to the individual white matter tracts. We
found that patterns of changes were influenced by measurable
neuroanatomical factors and that some patterns of injury
demonstrated a greater potential for reversibility than others
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FIGURE 6 | DTI profiles as line graphs comparing NPH cohorts across the spectrum (complex vs. classic NPH). DTI profiles for complex NPH responders mimicked
patterns of changes seen in classic NPH patients across all diffusivity measures (green brackets). MR1 = pre-intervention; MR2 = post-intervention.
(16). Predominant transependymal diffusion and stretch/oedema
patterns found in the corpus callosum and inferior fronto-
occipital/uncinate fasciculi, were less amenable to surgical
intervention. By contrast, in white matter tracts where a pattern
of stretch/compression was present, such as in the inferior
longitudinal fasciculus, or where stretch/compression was the
predominant pattern, such as in the posterior limb of the internal
capsule, it was possible to demonstrate significant changes as
early as 2 weeks following surgery (16). These changes, consistent
with improvement, preceded changes in clinical outcome and
were ultimately predictive of them. In this study, we have
similarly demonstrated that certain patterns of DTI morphology
are more responsive to CSF drainage than others. Complex NPH
patients who did not respond to extended CSF drainage exhibited
patterns consistent with axonal disruption and stretch/oedema
(increased mean (MD), axial and radial (L1 and L2and3)
diffusivities compared to healthy controls). Complex NPH
responders demonstrated worse DTI measures that patients with
classic NPH. However, white matter patterns in responders
appeared to bemore preserved, consistent with axonal disruption
and stretch/compression [increased mean and axial diffusivities
(MD and L1) but radial diffusivities (L2and3) not significantly
different to healthy controls]. By plotting changes in DTI
measures concurrently as profiles, it is possible to overcome the
methodological challenges of comparing statistically significant
datasets.
DTI Profiles for the Rapid Comparison of
Cohorts
Similarly, we have found, using DTI profiles, that despite
confounding factors such as comorbidities involving
cardiovascular risk burden and overlay from neurodegenerative
disease, complex NPH responders can be shown to demonstrate
patterns that mimic classic NPH responders across all diffusivity
measures. The changes exhibited by non-responders are
different and exhibit DTI morphology that are distinct from
responders. DTI is useful because of its ability to characterize
microarchitectural changes within white matter. The application
of DTI profiles allows for the interpretation of contrasting
pathological mechanisms without assumed prior knowledge
of the predominant patterns of changes leading to its clinical
syndrome. Our methodology of DTI profiles provides a
mechanism for describing morphological changes common
to different cohorts within the same spectrum of disease. This
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shorthand does not require that such groups are homogenous;
we have demonstrated its utility within separate and significantly
different patient cohorts within NPH, suggesting the DTI profiles
for the disease process is proportionately more important than
variations of the disease phenotype within its spectrum.
Limitations
Our study has several methodological shortcomings. Firstly,
our sample size is small, albeit relevant for the disease in
question. The current study reflects improvements in DTI
acquisition and analysis that is in some ways superior to that
of the exemplar dataset. An optimal comparator study would
involve simultaneous recruitment of different patient cohorts
across both collaborator sites, and would require harmonization
of DTI acquisition protocols in real time. Further validation
work regarding the use of DTI profiles in comparison with
international open-access datasets would be most helpful in this
regard.
In conclusion, comparability of DTI measures across disease
cohorts and collaborative sites is an obstacle to its usability and
application at the clinical-research interface. Our findings suggest
that it is possible to overcome such challenges by the use of
DTI profiles to understand the morphology of microstructural
changes and to apply such characterization in consistent terms to
international collaborator datasets. The use of such methodology
should be considered within the context of interdisciplinary
collaboration as part of the new praxis of translational medicine.
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